Published in Hum Reprod on August 06, 2004
Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc Natl Acad Sci U S A (2007) 1.27
Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung. Biol Reprod (2008) 1.20
Maternal background strain influences fetal-maternal trafficking more than maternal immune competence in mice. J Reprod Immunol (2011) 0.81
Role of fetal stem cells in maternal tissue regeneration. Gene Regul Syst Bio (2007) 0.76
Cigarette smoke exposure during pregnancy alters fetomaternal cell trafficking leading to retention of microchimeric cells in the maternal lung. PLoS One (2014) 0.75
First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med (2005) 4.89
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61
Assisted reproductive technology and pregnancy outcome. Obstet Gynecol (2005) 2.77
Transfer of fetal cells with multilineage potential to maternal tissue. JAMA (2004) 2.72
Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60
Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol (2008) 2.52
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
Intact fetal cells in maternal plasma: are they really there? Lancet (2003) 2.09
The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum (2003) 2.03
Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet (2013) 1.99
Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A (2009) 1.81
Quantification of green fluorescent protein by in vivo imaging, PCR, and flow cytometry: comparison of transgenic strains and relevance for fetal cell microchimerism. Cytometry A (2008) 1.72
Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA (2011) 1.59
Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem (2013) 1.55
Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol (2007) 1.46
Lessons learned from the introduction of personalized genotyping into a medical school curriculum. Genet Med (2011) 1.41
Genetic considerations in the prenatal diagnosis of overgrowth syndromes. Prenat Diagn (2009) 1.38
Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol (2005) 1.37
Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA (2005) 1.36
Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet (2010) 1.32
Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol (2006) 1.29
Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat Diagn (2009) 1.29
Neonatal salivary analysis reveals global developmental gene expression changes in the premature infant. Clin Chem (2009) 1.27
Early access to prenatal care: implications for racial disparity in perinatal mortality. Obstet Gynecol (2006) 1.27
Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci (2005) 1.26
Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol (2004) 1.25
Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem (2004) 1.23
Cervical cancer and microchimerism. Obstet Gynecol (2003) 1.21
The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol (2012) 1.20
Reproductive issues for adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2008) 1.20
Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers. Biol Reprod (2009) 1.20
Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung. Biol Reprod (2008) 1.20
DFLAT: functional annotation for human development. BMC Bioinformatics (2014) 1.17
Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest (2007) 1.09
Maternal cell microchimerism in newborn tissues. J Pediatr (2003) 1.08
Redefining the progeroid form of Ehlers-Danlos syndrome: report of the fourth patient with B4GALT7 deficiency and review of the literature. Am J Med Genet A (2013) 1.07
High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol (2005) 1.07
Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: Evidence of long-term survival and expansion. Hepatology (2002) 1.04
Fetal cell microchimerism: helpful or harmful to the parous woman? Curr Opin Obstet Gynecol (2003) 1.03
Microarray analysis of cell-free fetal DNA in amniotic fluid: a prenatal molecular karyotype. Am J Hum Genet (2004) 1.03
Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity (Silver Spring) (2012) 1.02
Optimal techniques for mRNA extraction from neonatal salivary supernatant. Neonatology (2011) 1.02
A new era in noninvasive prenatal testing. N Engl J Med (2013) 1.01
Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol (2004) 1.01
Global gene expression analysis of term amniotic fluid cell-free fetal RNA. Obstet Gynecol (2013) 1.00
The natural history of trisomy 12p. Am J Med Genet A (2006) 1.00
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem (2003) 0.99
Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome. Prenat Diagn (2013) 0.99
Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress. Am J Med Genet C Semin Med Genet (2007) 0.99
Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21. Hum Genet (2012) 0.97
Comparison of extraction techniques for amniotic fluid supernatant demonstrates improved yield of cell-free fetal RNA. Prenat Diagn (2011) 0.97
Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol (2002) 0.96
Neuropeptide Y2 receptor (NPY2R) expression in saliva predicts feeding immaturity in the premature neonate. PLoS One (2012) 0.96
Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci (2004) 0.96
The role of social networking sites in medical genetics research. Am J Med Genet A (2013) 0.96
Fetal cells in maternal tissue following pregnancy: what are the consequences? Hum Reprod Update (2004) 0.95
Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy. Fertil Steril (2004) 0.94
The contribution of birth defects to preterm birth and low birth weight. Obstet Gynecol (2007) 0.94
Array-CGH analysis of cell-free fetal DNA in 10 mL of amniotic fluid supernatant. Prenat Diagn (2007) 0.93
Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology. Cancer Res (2011) 0.92
Placental pathology in egg donor pregnancies. Fertil Steril (2009) 0.91
Larger columns and change of lysis buffer increase the yield of cell-free DNA extracted from amniotic fluid. Clin Chem (2006) 0.91
Prenatal treatment of Down syndrome: a reality? Curr Opin Obstet Gynecol (2014) 0.90
Fetal nucleic acids in maternal body fluids: an update. Ann N Y Acad Sci (2006) 0.90
Proof of concept study to assess fetal gene expression in amniotic fluid by nanoarray PCR. J Mol Diagn (2011) 0.90
Noninvasive prenatal testing: the paradigm is shifting rapidly. Prenat Diagn (2013) 0.90
Role of second-trimester genetic sonography after Down syndrome screening. Obstet Gynecol (2009) 0.90
Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome. Hum Genet (2014) 0.89
Combined FISH and immunolabeling on paraffin-embedded tissue sections for the study of microchimerism. Biotechniques (2003) 0.89